DEVELOPMENT OF CONVOLUTIONAL NEURAL NETWORK TO SEGMENT ULTRASOUND IMAGES
DOI:
https://doi.org/10.62643/Abstract
Histotripsy, a focused ultrasound therapy, effectively ablates tissue by leveraging bubble clouds and has potential for treating conditions such as renal tumors. To enhance monitoring and evaluation, this study combines classification and segmentation techniques using deep learning models. A convolutional neural network (CNN) was employed for classification, distinguishing treated and untreated tissue regions, while the U-Net model was utilized for precise segmentation of ablation zones in ultrasound images. The U-Net architecture was fine-tuned using transfer learning to optimize segmentation accuracy. Ultrasound images of ablated red blood cell phantoms and ex vivo kidney tissues were used for training and testing, with digital photographs serving as ground truth. The performance of these models was compared to manual annotations by expert radiologists. The CNN achieved high accuracy in classifying tissue states, and the U-Net demonstrated robust segmentation, closely matching expert manual annotations. Segmentation performance improved with increased treatment exposure, achieving a Dice similarity coefficient exceeding 85% for 750+ applied pulses. Application of the U-Net to ex vivo kidney tissue revealed morphological shifts consistent with histology findings, confirming targeted tissue ablation. The integration of CNNbased classification and U-Net segmentation demonstrated significant potential for automating and enhancing the monitoring of histotripsy outcomes. This combined approach offers a reliable and efficient means of visualizing treatment progress, supporting real-time decision-making during therapeutic procedures. The study highlights the capability of deep learning models to automate and improve treatment monitoring in histotripsy, paving the way for real-time, data-driven interventions.
Downloads
Published
Issue
Section
License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.













